Monte Carlo Simulations of the GE Signa PET/MR for Different Radioisotopes.
NEMA NU 2–2012
PET/MR
high energy positron emitters
nuclear medicine
positron range
Journal
Frontiers in physiology
ISSN: 1664-042X
Titre abrégé: Front Physiol
Pays: Switzerland
ID NLM: 101549006
Informations de publication
Date de publication:
2020
2020
Historique:
received:
09
01
2020
accepted:
13
08
2020
entrez:
12
10
2020
pubmed:
13
10
2020
medline:
13
10
2020
Statut:
epublish
Résumé
NEMA characterization of PET systems is generally based on Aim of this work was three-fold: (A) Develop a GATE model of the GE Signa PET/MR to perform realistic and relevant Monte Carlo simulations (B) Validate this model with published sensitivity and Noise Equivalent Count Rate (NECR) data for Simulated sensitivity and NECR tests performed with the GATE-model for different radioisotopes were in line with literature values. Simulated sensitivities for Monte-Carlo simulations were used to predict sensitivity and NECR performance of GE Signa PET/MR for
Identifiants
pubmed: 33041852
doi: 10.3389/fphys.2020.525575
pmc: PMC7522581
doi:
Types de publication
Journal Article
Langues
eng
Pagination
525575Informations de copyright
Copyright © 2020 Caribé, Vandenberghe, Diogo, Pérez-Benito, Efthimiou, Thyssen, D’Asseler and Koole.
Références
Phys Med Biol. 2016 Sep 7;61(17):6307-21
pubmed: 27494279
J Nucl Med. 1983 Nov;24(11):1060-4
pubmed: 6631527
Eur J Nucl Med Mol Imaging. 2020 Jan;47(1):51-60
pubmed: 31410538
IEEE Nucl Sci Symp Conf Rec (1997). 2014 Nov;2014:
pubmed: 27076778
J Nucl Med. 2017 Sep;58(9):1511-1518
pubmed: 28450566
Q J Nucl Med Mol Imaging. 2008 Jun;52(2):151-8
pubmed: 18043539
Appl Radiat Isot. 2013 Jun;76:2-13
pubmed: 23522791
Phys Med Biol. 2019 Sep 23;64(19):195003
pubmed: 31416055
PLoS One. 2014 Apr 22;9(4):e95250
pubmed: 24755872
Phys Med. 2016 Feb;32(2):323-30
pubmed: 26818471
Phys Med Biol. 1999 Mar;44(3):781-99
pubmed: 10211810
EJNMMI Phys. 2019 Jul 4;6(1):11
pubmed: 31273558
Nucl Med Biol. 2005 Apr;32(3):287-92
pubmed: 15820764
Eur J Nucl Med Mol Imaging. 2014 Jan;41(1):11-20
pubmed: 24072344
Phys Med Biol. 2013 Aug 7;58(15):5127-52
pubmed: 23835700
Phys Med Biol. 2019 Oct 16;64(20):205010
pubmed: 31539891
Methods. 2020 Jan 30;:
pubmed: 32006678
J Nucl Med. 2010 Sep;51(9):1431-8
pubmed: 20810759
Phys Med Biol. 2019 Jan 22;64(3):035004
pubmed: 30566915
Phys Med Biol. 2012 Jun 21;57(12):3931-43
pubmed: 22643300
Med Phys. 2016 May;43(5):2334
pubmed: 27147345
Phys Med Biol. 2004 Oct 7;49(19):4543-61
pubmed: 15552416
Nucl Instrum Methods Phys Res A. 2011 Aug 21;648 Supplement 1:S236-S240
pubmed: 21804677
Ann Neurol. 1979 Nov;6(5):371-88
pubmed: 117743
Med Phys. 1994 Dec;21(12):1917-20
pubmed: 7700198
EJNMMI Phys. 2014 Jul;1(Suppl 1):A50
pubmed: 26501639
Phys Med Biol. 1997 Oct;42(10):1965-70
pubmed: 9364592
Semin Nucl Med. 2011 Jul;41(4):246-64
pubmed: 21624560
IEEE Trans Med Imaging. 2016 Aug;35(8):1907-14
pubmed: 26978664
IEEE Trans Med Imaging. 1995;14(4):681-7
pubmed: 18215872
EJNMMI Phys. 2016 Dec;3(1):8
pubmed: 27271304
Eur J Nucl Med Mol Imaging. 2011 May;38 Suppl 1:S10-8
pubmed: 21484385
Eur J Nucl Med Mol Imaging. 2011 May;38(5):940-8
pubmed: 21287170
EJNMMI Phys. 2016 Dec;3(1):3
pubmed: 26879863
Phys Med Biol. 2012 May 7;57(9):N101-15
pubmed: 22481596
Clin Nucl Med. 2015 Jan;40(1):1-8
pubmed: 25489952
J Nucl Med. 2015 Jun;56(6):951-4
pubmed: 25766897